dc.date.accessioned2019-12-06T20:57:47Z
dc.date.available2019-12-06T20:57:47Z
dc.date.created2019-12-06T20:57:47Z
dc.date.issued2019
dc.identifierhttps://hdl.handle.net/20.500.12866/7407
dc.identifierhttps://doi.org/10.1177/1533317519869709
dc.description.abstractOBJECTIVES: To assess the psychometric properties of the Peruvian version of the Rowland Universal Dementia Assessment Scale (RUDAS-PE) to discriminate controls from patients with mild cognitive impairment (MCI) and early dementia (ED) in a population with a mid-level education. METHODS: A total of 133 patients from a memory clinic were administered the RUDAS-PE, INECO Frontal Screening, Addenbrooke's Cognitive Examination, and Mini-Mental State Examination. Results were compared against a neuropsychological evaluation (gold standard). Validity measures, internal consistency, and concurrent validity were calculated. RESULTS: Cronbach's alpha was 0.68; Pearson's ratio was 0.79 (P < .01). The area under the receiver-operating characteristics curve of the RUDAS to discriminate between ED and MCI was 89.0% (optimal cutoff at <21), whereas between MCI and controls, it was 99.0% (optimal cutoff at <24). CONCLUSIONS: The RUDAS-PE has acceptable psychometric properties performing well in its ability to discriminate controls from patients with MCI and ED.
dc.languageeng
dc.publisherSAGE Publications
dc.relationAmerican Journal of Alzheimer's Disease and Other Dementias
dc.relation1938-2731
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectAddenbrooke Cognitive Examination
dc.subjectaged
dc.subjectAlzheimer disease
dc.subjectAlzheimer's disease
dc.subjectAlzheimer’s disease
dc.subjectaminotransferase
dc.subjectArticle
dc.subjectBeck Depression Inventory
dc.subjectbrief cognitive tests
dc.subjectClinical Dementia Rating
dc.subjectcognitive impairment
dc.subjectcomputer assisted tomography
dc.subjectcontrolled study
dc.subjectcreatinine
dc.subjectcyanocobalamin
dc.subjectdementia
dc.subjectdementia assessment
dc.subjectdiagnostic accuracy
dc.subjectdiagnostic test accuracy study
dc.subjectdisorders of higher cerebral function
dc.subjectDSM-5
dc.subjecteducation
dc.subjectenzyme linked immunosorbent assay
dc.subjectfemale
dc.subjectfolic acid
dc.subjectfree liothyronine index
dc.subjectfree thyroxine index
dc.subjectglucose
dc.subjectgold standard
dc.subjecthuman
dc.subjectINECO Frontal Screening
dc.subjectLikert scale
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmild cognitive impairment
dc.subjectneurocognitive disorders
dc.subjectneuropsychological test
dc.subjectneuropsychological tests
dc.subjectnuclear magnetic resonance imaging
dc.subjectoutcome assessment
dc.subjectPeru
dc.subjectpilot study
dc.subjectpredictive value
dc.subjectpsychometry
dc.subjectquestionnaire
dc.subjectreceiver operating characteristic
dc.subjectRey auditory verbal learning test
dc.subjectRowland Universal Dementia Assessment Scale
dc.subjectscoring system
dc.subjectsensitivity and specificity
dc.subjectthyrotropin
dc.subjecttrail making test
dc.subjecturea
dc.subjectvalidation process
dc.subjectWechsler adult intelligence scale
dc.subjectWechsler memory scale
dc.subjectWisconsin Card Sorting Test
dc.titleValidation of the RUDAS in Patients With a Middle-Level Education in Lima, Peru.
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución